User profiles for Tristan P Hurzeler

Tristan Hurzeler

Sydney University
Verified email at sydney.edu.au
Cited by 68

Reporting of alcohol as a contributor to death in Australian national suicide statistics and its relationship to post‐mortem alcohol concentrations

…, JL Schumann, LL Moran, DG Chong, TP Hurzeler… - …, 2021 - Wiley Online Library
Aim To describe the assignment of International Classification of Disease (ICD)‐10 alcohol
codes as underlying or contributory causes of death by the Australian Bureau of Statistics …

N-acetyl Cysteine attenuates intrinsic functional connectivity, but not neural alcohol cue reactivity, in treatment-seeking individuals with alcohol use disorder

WB Logge, PS Haber, TP Hurzeler, EE Towers… - medRxiv, 2023 - medrxiv.org
N-acetyl cysteine (NAC) is a potential pharmacotherapy for alcohol use disorder (AUD), but
it is not known whether it modulates neural activation to alcohol cues or intrinsic functional …

[HTML][HTML] Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review

T Hurzeler, J Watt, W Logge, E Towers… - Journal of Cannabis …, 2024 - Springer
… CBD significantly increased spontaneous fluctuations in BOLD signal across both groups
in the right fusiform gyrus (p = 0.041) and in the cerebellar vermis (p = 0.048) which post-hoc …

Psychosocial interventions for reducing suicidal behaviour and alcohol consumption in patients with alcohol problems: a systematic review of randomized controlled …

T Hurzeler, V Giannopoulos, G Uribe… - Alcohol and …, 2021 - academic.oup.com
Objective We aimed to provide a synthesis and evaluation of psychosocial interventions to
prevent suicide and reduce self-harm, as well as alcohol intake, for patients with alcohol …

Hypothalamic-pituitary-adrenocortical response in alcohol-dependent patients during baclofen treatment and association with clinical outcome: Preliminary results

W Logge, T Hurzeler, S Arunogiri, E Towers, A Baillie… - Alcohol, 2023 - Elsevier
Baclofen has been shown to reduce alcohol consumption in some individuals with alcohol
use disorder. This preliminary study aimed to evaluate i) the effect of baclofen versus placebo …

[HTML][HTML] Alcohol‐related suicide across Australia: a geospatial analysis

T Hurzeler, NA Buckley, F Noghrehchi, P Malouf… - Australian and New …, 2021 - Elsevier
Background The acute effects of alcohol consumption are a major risk factor for suicide.
Positive blood alcohol concentrations are present in almost one‐third of all suicides at time of …

Central markers of neuroinflammation in alcohol use disorder: A meta‐analysis of neuroimaging, cerebral spinal fluid, and postmortem studies

…, N Perry, J Conigrave, T Hurzeler… - Alcohol: Clinical and …, 2023 - Wiley Online Library
Introduction and aims There is emerging evidence that heavy long‐term alcohol consumption
may alter the neuroimmune profile. We conducted a meta‐analysis of the association …

Assessing the validity of the Wechsler Adult Intelligence Scale (WAIS-IV) in predicting completion in a long-term residential rehabilitation for substance use problems

…, N Ridley, LA Monds, W Logge, T Hurzeler… - Applied …, 2023 - Taylor & Francis
Background We aimed to examine the predictive validity of the Weschler Adult Intelligence
Scale (WAIS-IV) in predicting treatment completion, over and above educational status. …

[HTML][HTML] Sex as a potential moderator for baclofen response in the treatment of alcohol dependence

KC Morley, E Louie, T Hurzeler, A Baillie… - Frontiers in Global …, 2022 - frontiersin.org
Background and Aims: Recent studies indicate that sex may moderate response to baclofen
in the treatment of alcohol use disorder. We conducted a secondary analysis of the BacALD …

New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies

KC Morley, CJ Perry, J Watt, T Hurzeler… - Expert Opinion on …, 2021 - Taylor & Francis
Abstract introduction: The number of medications approved for AUD is small and they
generally have limited efficacy. We need new pharmacotherapies for the management of AUD. …